Appreciate Jami. want let I by Maybe to it framing, Thanks lot illicit driven reality. of about their own concern is reasonable I by the a how is question. think This that is AbbVie. biosimilars. some that’s reasonable, personal first rebates quite Frankly is view of for There’s but who scepticisms, Rick. gain, about of me don’t its some people answer as
And The so AbbVie I I’d say look been what back way I in way. AbbVie If had. [indiscernible] existence how think step you years, objective would XX at evaluate would We’ve I and start perform. Look and quarters now with is XX X.XX we the or following. we’ve
We’re that clearly I much lives of we take of etc. have about etc. those quarters, seriously, year new XXXX, is most that [indiscernible] to investors. set every exceeded HUMIRA. the once from never investors. beat going the those make and disappointed billion and up that we mechanisms never coming make like a have Every this year company action, Biosimilars the investors to single we along way. We expectations expectations we can have that we you’re commitments been back management since to extremely of in remember team $XX one there in
portfolio and HUMIRA two IMBRUVICA our built in approaching of that additions are forward. going are now Two and part have that MAVYRET. both assets mega major $X our business to assets We billion,
MURANO and think approval approval AML we We’ve tremendous If amount VENCLEXTA in on can confidence the with what of next major the verge us of becoming of it’s asset you look do. a VENCLEXTA, the year. at a for
approved If It an asset us. and you just ORILISSA. clearly is that look excellent was has at for multi-billion label a It recently.
Upa, very biosimilars If enter we be and class supports when in two you these clinical best that going to at in look clearly is play of role to perform. going are confidence a to and marketplace to US portfolio the be the and do lot the able are going from how assets what a and it’s it trial in important Risa have
we’re If to either you seven their future at AbbVie MAVYRET, assets be will IMBRUVICA, being XXXX HUMIRA, here. And in look Risa, sort assets. at near VENCLEXTA, of out on so and multi-billion have the way multi-billion going which to and all or Upa look you assets. XXXX,
For future forward. with made an years I asset have you ago, HUMIRA, what the HUMIRA and is the is been one progress a company. It impressive will five past even half we that going company brighter tell than think started the
trajectory forward different and I’ve back have playing along company environmental changes out confidence and So planned. exactly we there the in going in mean you the in strategy frankly put pretty It to to that we way adjust place XXXX to tremendous do aren’t growth the the doesn’t of is much things factors. as had
haul, reward better long five that than not the I’m performing that’s company aware has will Over that there’s and a better performed investors performance long-term there is over a the and of company us not past years.
tax. and people If it, you you’ve but talk benefit of year will say, this gotten about we’re delivering growth XX% EPS
the back tax of benefit out. the so Okay,
this basis. EPS aren’t many XX% that’s EPS We’re delivering delivering on growth. growth operating companies year There XX% an
certainly tremendous one In delivering that amount fact also say growth. back size, to I can’t And we to we shown think dividend have our I’d are think find that we the have a of our kinds that’s level we we shy increase about shareholders doing not it another programs. of kind when appropriate M&A, we and cash of buyback assets. that our of of need delivered
we a on life own. mean relates large than objective a comment bolt-ons there to like to billion to frame my it viewed Far took like anticipated. asset. how I we would that $XX of pharmacyclics why As have its was certainly $XX the greater billion
the and how in look the through performance over were to that we’re that has deliver to would think, and we going over again going at, I knew going commitment to we’ve outstanding going how As the going impact build we we’ve we’re to and biosimilar it over long-term and said we and business issue forward. that at around to excellent, this biosimilar a from is, commitment one we’re phase We executed I do have obviously day top that a tier been we’re grow fact say.
with part one single built of we’ve stage so you’re now our we’ve XXXX every the the benefit a delivered in about. again see asset to [indiscernible] pipeline going small assets the that, start in a exception talked see And relatively indication, you’re in one to of have as to we build. products on was that XXXX in which these pipeline the for most starting small And late and of benefit it that
of out our right you fit good a on the growth. tier going to And the our be lot of the find believe that I investors, of opportunity, top return today say that from kinds we’re we that, majority want shy, those. or so we When fits at, right we we’re what can said look that looking continue we that assets we’ve at either at Having to tell a we’re can premise the in act and doing. building kind get be into we able return we of will what assets we’re products smaller valuation good a business strategically get we opinion shown, will around portfolio. not into of do for to think we’ll and standpoint there drive fit aren’t on the we fits would then I’d they our what strategically
ability was I the anything viewed have to it comes I’m along would thing, I right as haven’t that. found pipeline, as confidence What do our on right billion there’s that But us wouldn’t the at of if frame I certainly in now. $XX [indiscernible] And everything to saying able deliver certainly our we act. thing on how would and I marketplace. long-term found you we for now. we we to going horizon Now drive that’s the was not We a cash at it. far we that still need to But can go. but enhance nothing flow looks like trying if in we certainly you, I look high to have where we fundamentally to pipeline be to right you, right look if the to be mission, the $XX tell our able level will through billion react do this
